Generalized Anxiety Disorder

Generalized anxiety disorder (GAD) is characterized by persistent, excessive, and difficult-to-control worry about everyday matters, accompanied by physical and cognitive symptoms such as restlessness, fatigue, muscle tension, and difficulty concentrating. The worry is out of proportion to actual circumstances and continues for months, distinguishing GAD from ordinary anxiety. It is a common, often chronic disorder that frequently co-occurs with depression and other anxiety disorders.

Definition

Generalized anxiety disorder is a condition marked by excessive, persistent, and uncontrollable worry about multiple domains of life, present more days than not for at least six months and accompanied by symptoms such as restlessness, fatigue, irritability, muscle tension, and sleep disturbance, causing clinically significant distress or impairment.

Scope

This entry covers the clinical definition, core features, mechanisms, epidemiology, and evidence base of GAD as a distinct diagnostic entity within the anxiety disorders. It addresses the nature of pathological worry and the disorder's high comorbidity, and it summarizes the evidence for psychological and pharmacological treatment at a population level. It is reference-educational and does not provide individual diagnostic or treatment guidance.

Core questions

• How is pathological, generalized worry distinguished from normal anxiety and from worry confined to a single phobic object?
• What cognitive and neurobiological processes maintain chronic worry?
• Why does GAD so often co-occur with major depression?
• What interventions have the strongest evidence in GAD?

Key concepts

• Excessive, uncontrollable worry
• Chronic course and waxing-waning severity
• Somatic tension and autonomic symptoms
• Intolerance of uncertainty
• Comorbid depression
• Functional impairment

Key theories

Worry as cognitive avoidance

Influential models propose that chronic worry functions partly as a verbal-linguistic activity that dampens vivid imagery and somatic arousal, thereby negatively reinforcing itself while preventing emotional processing - a mechanism that helps explain why worry is persistent and hard to control.

Mechanisms

GAD is understood as a disorder of the fear and anxiety systems in which apprehension becomes generalized and self-sustaining rather than tied to a specific threat. Cognitive models emphasize intolerance of uncertainty and the role of worry as a strategy that paradoxically maintains anxiety by blocking emotional processing of feared outcomes. Neurobiological accounts implicate altered function in prefrontal-amygdala circuits and dysregulation of serotonergic, noradrenergic, and GABAergic systems, consistent with the response of GAD to serotonergic agents.

Clinical relevance

GAD is a frequent presentation in primary care, where it commonly appears with physical complaints and alongside depression, and it contributes substantially to disability and health-care use. This entry describes how the disorder is defined and studied to support understanding and appraisal of evidence; it is not a basis for individual diagnosis or treatment decisions.

Epidemiology

GAD is one of the more common anxiety disorders, with substantial lifetime and 12-month prevalence in general-population surveys such as the National Comorbidity Survey Replication, a female preponderance, and frequent comorbidity with major depression and other anxiety disorders. Onset is often gradual and the course tends to be chronic and fluctuating.

Evidence & guidelines

Cognitive behavioral therapy and serotonergic medications (SSRIs and SNRIs) are the best-supported treatments, with meta-analytic evidence for CBT across anxiety and related disorders. Diagnostic criteria are specified in DSM-5-TR and ICD-11 (where GAD is coded 6B00), and disorder-specific clinical guidelines exist; this entry summarizes the evidence base rather than recommending a regimen.

History

GAD emerged as a distinct diagnosis in DSM-III (1980) when the broad category of anxiety neurosis was subdivided, initially as a residual category and later refined around the central feature of excessive, uncontrollable worry. Subsequent revisions strengthened the worry criterion and the chronicity requirement, and contemporary classifications (DSM-5-TR, ICD-11) treat it as a defined anxiety disorder.

Debates

Is GAD better understood as an independent disorder or as part of a shared internalizing dimension with depression?

The very high comorbidity and shared genetic and temperamental vulnerability between GAD and major depression have led some to question their categorical separation, while others maintain that distinct cognitive features such as pathological worry justify a separate diagnosis.

Key figures

• Murray Stein
• Michelle Craske
• Thomas Borkovec
• Ronald Kessler

Seminal works

• kessler-2005
• stein-2015
• craske-2017

Frequently asked questions

How is generalized anxiety disorder different from everyday worry?

In GAD the worry is excessive, hard to control, spans many areas of life, persists most days for at least six months, and is accompanied by symptoms such as restlessness, fatigue, and muscle tension that cause distress or impairment - features that distinguish it from ordinary, proportionate worry.

Why does GAD often occur with depression?

GAD and major depression share genetic, temperamental, and cognitive vulnerabilities, which is reflected in their high rates of co-occurrence in epidemiologic studies. This overlap is a topic of ongoing classification debate.